Building A Better Drug Portfolio: Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), Amgen, Inc. (AMGN)
When building a drug portfolio, most investors stick to pharmaceutical firms. Since these are generally the largest, most profitable options, it's easy to see why.
